Microelectronic Medical Implants Market Scope And Analysis

Report Code : TIPHE100001242
Category : Life Sciences

No. of Pages : 150

Buy Now

Micro-Electronic Medical Implants Market Analysis and Scope (2024 to 2031)

Buy Now

Micro-Electronic Medical Implants Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 39.21 Billion
Market Size by 2031	US$ 85.29 Billion
Global CAGR (2023 - 2031)	9.4%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Product Neurostimulators Cochlear Implants Retinal Implants Pacemakers & Defibrillators Implantable Drug Pumps Ocular Implants By Technology RF Technology Sensors By Material Metals Polymers Ceramics By Application Cardiology Neurology Oncology Ophthalmology
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Sonova NeuroPace Inc ABBOTT Medtronic Cochlear Ltd LivaNova PLC Abiomed Boston Scientific Corporation BIOTRONIK SE Co KG Zimmer Biomet

Micro-Electronic Medical Implants Market News and Recent Developments

The micro-electronic medical implants market is evaluated by gathering qualitative and quantitative data from primary and secondary research, which includes essential corporate publications, association data, and databases. A few of the developments in the Micro-electronic medical implants market are listed below:

MicroPort CRM, announced the launch of the ULYS Implantable Cardioverter Defibrillator (ICDs) and INVICTA defibrillation lead in Japan. Both devices are MRI conditional at 1.5T and 3T when implanted as a system. The ULYS ICD has advanced technology with low current consumption, resulting in a longer predicted lifespan compared to other ICD devices. (Source: MicroPort CRM, Press Release, October 2023)
Medtronic plc announced availability of its FDA-approved InterStim Micro neurostimulator for sacral neuromodulation (SNM) therapy in the US. Cleveland Clinic performed the first patient implant in the nation with the new device. (Source Medtronic plc, Press Release, 2020)

Micro-Electronic Medical Implants Market Report Coverage and Deliverables

The “Micro-Electronic Medical Implants Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Micro-electronic medical implants market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Micro-electronic medical implants market trends, as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
Micro-electronic medical implants market analysis covering key market trends, global and regional framework, significant players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the micro-electronic medical implants market
Detailed company profiles